Skip to content

Clinical trials

Completed Carcinoid Tumor trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoid Tumor Status: Completed Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20042
20052
20066
20083
20094
20105
20114
20122
20132
20141
20155
20162
20192
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Dana-Farber Cancer Institute7
H. Lee Moffitt Cancer Center and Research Institute4
Suez Canal University3
Sue O'Dorisio2
Advanced Accelerator Applications1
Amgen1
Arbutus Biopharma Corporation1
Brahms AG1
CASI pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoid Tumor48
Neuroendocrine Tumors26
Neoplasms9
Adenoma, Islet Cell8
Neoplasm Metastasis8
Carcinoma7
Carcinoma, Neuroendocrine4
Pheochromocytoma4
Sarcoma4
Colorectal Neoplasms3

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.